October 2021 - Transporters in Drug Screening and Toxicity Testing
Dr. Roberta Benedetto, Scientist; Assay.Works
Title: SURFE2R-Based Assays for Mitochondrial Toxicity Screening and Intestinal Transporter-Mediated Drug Delivery
Dr. Thomas Licher, Head of Integrated Drug Discovery; Sanofi
Title: SSM-Based Technology for Screening of Transporter Modulating Compounds – a Case Study
Transport proteins and pumps are getting more established as drug targets. However, the set of available technologies for screening and hit validation is lean. In session four of the Transporter Webinar Series we hear from experts in the pharma field how SSM-based electrophysiology can support transporter drug screening as a potent tool.
Register for our monthly Newsletter and we will keep you informed.